$9.17
Today
as of Jul 22, 16:50 ET
Last 30 days
Recent Press Releases & News
Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026
Immatics Presents Clinical Activity and Response Dynamics of Anzu-cel PRAME Cell Therapy at 2026 ASCO Annual Meeting
Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer
Overview
52-week range
$5.05
$12
56% of range
Avg surprise (last 3)
-27.5%
Avg reaction (last 2)
-3.1%
0% positive
Latest IV / EM
196%
EM ±30.7% · $10 · Jul 17
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 12, 2026 | Mar/2026 | $-0.50 | $-0.42 | -19.1% | -42.9% | -1.3% | earnings |
| Wed Aug 13, 2025 | Jun/2025 | $-0.66 | $-0.38 | -73.7% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.35 | $-0.39 | +10.3% | — | -4.8% | earnings |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 12, 2026 | Jun/2026 | OTHER | -$0.43 | -$0.66 | +34.9% |